Medical Research Institute

Slidell, Louisiana 70458

0 studies enrolling now · 14 studies all time

What they study most

Acute Decompensation of Chronic Heart Failure, Acute Heart Failure, Atherosclerosis, Atrial Fibrillation, Congestive Heart Failure, Coronary Artery Disease, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2, Gastroparesis, Heart Failure, Congestive, Hypertension, Myocardial Infarction

Studies at this site

Tezosentan in the Treatment of Acute Heart Failure — Completed
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus — Completed
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes — Completed
A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects — Completed
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension — Completed
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension — Stopped early
A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures. — Completed
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation. — Completed
Obese Patients With Type 2 Diabetes — Completed
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. — Completed
ARISE - Aggressive Reduction of Inflammation Stops Events — Status unconfirmed
Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis — Completed
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients — Completed
Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients — Completed